Valneva SE (WBO:VLA) 3-Year Book Growth Rate : 2.70% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Valneva SE 3-Year Book Growth Rate?

Valneva SE's Book Value per Share for the quarter that ended in Sep. 2024 was €1.34.

During the past 12 months, Valneva SE's average Book Value per Share Growth Rate was 18.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 2.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was -5.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Valneva SE was 52.50% per year. The lowest was -21.50% per year. And the median was 1.75% per year.

Competitive Comparison of Valneva SE's 3-Year Book Growth Rate

For the Biotechnology subindustry, Valneva SE's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valneva SE's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Valneva SE's 3-Year Book Growth Rate falls into.

Valneva SE 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Valneva SE (WBO:VLA) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Valneva SE 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Valneva SE's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (WBO:VLA) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

VALN:USA INRLF:USA VLAp:UK 0OB3:UK VLA:France AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Germany AYJ:Bulgaria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

No Headlines